Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-410734

Chief Operating Officer sold 10,000 shares at an average $33.19 ($331,856)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gault Cheryl Chief Operating Officer 2026-09-30 Sale 10b5-1 −7,925 $33.04 $261,813 141,989 D: show line 1 in the form
Gault Cheryl Chief Operating Officer 2026-09-30 Sale 10b5-1 −2,075 $33.76 $70,043 139,914 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $33.19 · $331,856
Loading xslF345X06/ownership.xml…